Skip to main content
. Author manuscript; available in PMC: 2024 Apr 1.
Published in final edited form as: Mayo Clin Proc. 2022 Dec 20;98(4):533–540. doi: 10.1016/j.mayocp.2022.10.028

Table 2.

Distribution and prevalence odds ratio of cardiovascular risk factors and cardiovascular diseases among carriers of a heterozygous variant in the leptin-melanocortin pathway.

All
(n = 2207)
Carriers
(n = 168)
Univariate OR
(95% CI)
p-value Model 1a OR (95% CI) p-value Model 2b OR
(95% CI)
p-value
Cardiovascular Risk Factors
Hypertension, yes 1005 (45.5%) 120 (71.4%) 3.26 (2.31 – 4.61) <.001 3.31 (2.33 – 4.71) <.001 3.32 (2.34 – 4.73) <.001
Diabetes, yes 1000 (45.3%) 88 (52.4%) 1.35 (0.99 – 1.86) .05 1.32 (0.95 – 1.83) .09 1.34 (0.96 – 1.86) .08
Dyslipidemia, yes 1704 (77%) 129 (76%) 0.97 (0.67 – 1.41) .89 0.95 (0.63 – 1.43) .82 0.96 (0.63 – 1.45) .84
Smoke, yes 915 (41.4%) 64 (38.1%) 0.85 (0.62 – 1.18) .36 0.84 (0.61 – 1.17) .32 0.86 (0.61 – 1.19) .35
Cardiovascular Diseases
CAD, yes 611 (27.7%) 45 (26.8%) 0.95 (0.73 – 1.49) .78 0.89 (0.60 – 1.31) .55 0.91 (0.62 – 1.35) .66
PAD, yes 717 (32.5%) 48 (28.5%) 0.95 (0.52 – 1.72) .35 0.74 (0.50 – 1.09) .13 0.75 (0.51 – 1.10) .22
CVA, yes 248 (11.2%) 17 (10.1%) 0.86 (0.52 – 1.48) .63 0.86 (0.50 – 1.46) .57 0.87 (0.50 – 1.49) .61

Abbreviations: CAD, coronary artery disease; CVA, cerebrovascular accident; CVD, cardiovascular disease; PAD, peripheral arterial disease.

a

Adjusted for age and body mass index.

b

Adjusted for age, sex and body mass index.